Alex Stojanovic
VP Business Development
Phosphagenics
Australia
Biography
Dr Stojanovic joined Phosphagenics in early 2014. He has spent seven years as a strategy consultant, during which time he has advised more than 30 life science companies on various aspects of business development, corporate strategy, marketing, and market access. Dr Stojanovic also served as Senior Director of Global New Compound Marketing at Grunenthal GmbH, managing the global commercial development of two pipeline pain molecules. He received a PhD in Pharmacology & Toxicology from Dartmouth College, USA and BS degrees in Chemistry and Cell & Structural Biology from the University of Illinois, USA.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management
